- 全部删除
- 您的购物车当前为空
Anti-NAA10/ARD1 Antibody (5R484) 是一种 Mouse 抗体,靶向 NAA10/ARD1。Anti-NAA10/ARD1 Antibody (5R484) 可用于 ELISA。
Anti-NAA10/ARD1 Antibody (5R484) 是一种 Mouse 抗体,靶向 NAA10/ARD1。Anti-NAA10/ARD1 Antibody (5R484) 可用于 ELISA。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
100 μL | ¥ 1,694 | 5日内发货 |
产品描述 | Anti-NAA10/ARD1 Antibody (5R484) is a Mouse antibody targeting NAA10/ARD1. Anti-NAA10/ARD1 Antibody (5R484) can be used in ELISA. |
别名 | TE2, OGDNS, NATD, NAA10, N(α)-acetyltransferase 10, NatA catalytic subunit, N(alpha)-acetyltransferase 10, NatA catalytic subunit, MCOPS1, DXS707, ARD1P, ARD1A, ARD1 |
Ig Type | Mouse IgG1 |
克隆号 | 5R484 |
交叉反应 | Human |
应用 | ELISA |
推荐剂量 | ELISA: 1:1000-1:2000 |
抗体种类 | Monoclonal |
宿主来源 | Mouse |
构建方式 | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human ARD1 (rh NAA10; TMPY-03339; P41227; Met1-Ser235). |
纯化方式 | Protein A |
性状 | Liquid |
缓冲液 | 0.2 μm filtered solution in PBS |
研究背景 | ARD1 is a member of the 2-kDa ARF protein family. It is a multifunctional protein. ARD1 has an 18-kDa ADP-ribosylation factor (ARF) domain at the C-terminus (amino acids 43-574), and a 46-kDa N-terminal domain (amino acids 1-42). The C-terminal region of ARD1 may be involved in the formation of both ARD1-ARD1 and ARD1-NAT1 complexes. ARD1 and NAT1 genes are required for the expression of an N-terminal protein acetyltransferase. This activity is required for full repression of the silent mating-type locus HML, for sporulation, and for entry into G. Recombinant ARD1 (amino acids 1-574) or its RING finger domain (amino acids 1-11) produced polyubiquitylated proteins when incubated in vitro with a mammalian E1, an E2 enzyme, ATP, and ubiquitin. |
偶联 | Unconjugated |
免疫原 | Recombinant Protein: Human ARD1 protein (TMPY-03339) |
抗原种属 | Human |
储存方式 | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
运输方式 | Shipping with blue ice. |
评论内容